Evidence map›Paper›PMID 37961893›Full record

ArticleHuman vaccines & immunotherapeutics2023

Association between sex hormones and anti-S/RBD antibody responses to COVID-19 vaccines in healthcare workers.

Simona Anticoli, Maria Dorrucci, Elisabetta Iessi, Flavia Chiarotti, Reparata Rosa Di Prinzio, Maria Rosaria Vinci, Salvatore Zaffina, Vincenzo Puro, Francesca Colavita, Klizia Mizzoni and 6 more

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Simona AnticoliReference Center for Gender-specific Medicine, Istituto Superiore di Sanità [Italian National Institute of Health], Rome, Italy.
Maria DorrucciDepartment of Infectious Diseases, Istituto Superiore di Sanità [Italian National Institute of Health], Rome, Italy.
Elisabetta IessiReference Center for Gender-specific Medicine, Istituto Superiore di Sanità [Italian National Institute of Health], Rome, Italy.
Flavia ChiarottiReference Center for the Behavioural Sciences and Mental Health, Istituto Superiore di Sanità, [Italian National Institute of Health], Rome, Italy.
Reparata Rosa Di PrinzioOccupational Medicine Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Maria Rosaria VinciOccupational Medicine Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Salvatore ZaffinaOccupational Medicine Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Vincenzo PuroUOC Emerging Infections and CRAIDS, National Institute for Infectious Diseases L. Spallanzani IRCSS, Rome, Italy.
Francesca ColavitaUOC Lab of Virology, National Institute for Infectious Diseases L. Spallanzani IRCSS, Rome, Italy.
Klizia MizzoniUOC Lab of Virology, National Institute for Infectious Diseases L. Spallanzani IRCSS, Rome, Italy.
Silvia MeschiUOC Lab of Virology, National Institute for Infectious Diseases L. Spallanzani IRCSS, Rome, Italy.
Nicoletta VoneschDepartment of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers' Compensation Authority (INAIL), Monte Porzio Catone, Rome, Italy.
Christian AlbanoB cell Lab, Immunology Research Area, Bambino Gesù Children's Hospital, Rome, Italy.
Elena OrtonaReference Center for Gender-specific Medicine, Istituto Superiore di Sanità [Italian National Institute of Health], Rome, Italy.
Anna RuggieriReference Center for Gender-specific Medicine, Istituto Superiore di Sanità [Italian National Institute of Health], Rome, Italy.
Paola TomaoDepartment of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers' Compensation Authority (INAIL), Monte Porzio Catone, Rome, Italy.
Istituto Superiore di Sanità · ITBambino Gesù Children's Hospital · ITAccident Compensation Corporation · NZCenter for Prevention and Treatment of Infections · USIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Healthcare workers (HCWs) are the target population for vaccination against coronavirus disease (COVID-19) as they are at a high risk of exposure and transmission of pathogens to patients. Neutralizing antibodies developed after COVID-19 vaccination decline within few months of vaccination. Several factors, including age and sex, can affect the intensity, efficacy, and duration of immune response to vaccines. However, sex-specific analyses of humoral responses to COVID-19 vaccines are lacking. This study aimed to evaluate sex-based differences in anti-S/RBD (Receptor Binding Domain) responses at three different time points after the second dose of mRNA COVID-19 vaccine in HCWs in relation to age, and to investigate the role of sex hormones as potential markers of response. Anti-S/RBD levels after two doses of the mRNA vaccine were collected from 521 HCWs naïve to COVID-19, working at two Italian Clinical Centers. Multiple regression analysis was applied to evaluate the association between anti-S levels and sex, age, and plasma levels of sex hormones. Significantly higher anti-S/RBD response to the COVID-19 vaccination was found in female HCWs, and a significant and more abrupt decline in response with time was observed in women than that in men. A novel, positive association of testosterone plasma levels and higher anti-S levels in male HCWs was found, suggesting its potential role as sex specific marker in males. In conclusion, understanding the sex-based differences in humoral immune responses to vaccines may potentially improve vaccination strategies and optimize surveillance programs for HCWs.

Indexed as

Antibody FormationCOVID-19Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesFemaleGonadal Steroid HormonesHealth PersonnelHumansMaleVaccinationAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesGonadal Steroid Hormonesanti-S/RBDCOVID-19estrogenhealthcare workersprogesteronesex differencetestosteronevaccine

Identifiers

PMID37961893
PMCPMC10760357
OpenAlexW4388658499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.